| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |